AI Scribe for Endocrinologists
T2DM follow-ups, T1DM with insulin pumps, thyroid clinics, adrenal workups, PCOS, and CGM-review visits — documented in seconds. PatientNotes captures A1c trends, GLP-1 / insulin titration, time-in-range from Dexcom or Libre, TSH and free T4, then maps them to the right CPT (99214, 95251) and ICD-10 codes.
Documentation for Every Endocrinology Visit
From a 15-minute thyroid follow-up to a complex pump-and-CGM T1DM titration, PatientNotes uses the right structure for the visit.
Type 2 Diabetes Management
A1c trend, fasting glucose, BMI, GLP-1 / SGLT2 / metformin / insulin titration, microalbumin, foot exam, retinal exam, and ASCVD risk reduction.
Type 1 DM Insulin Titration
Pump basal/bolus rates, ICR and ISF tuning, CGM time-in-range, hypo unawareness assessment, and AID (automated insulin delivery) review.
Thyroid Disease
Hypothyroid (TSH, free T4, levothyroxine titration), Graves and toxic nodular goiter (T3 toxicosis, methimazole, RAI), nodules (Bethesda), post-thyroidectomy follow-up.
Adrenal Disorders
Primary and secondary adrenal insufficiency, Cushing workup (24-hour urine cortisol, late-night salivary, dexamethasone suppression), pheochromocytoma, incidentaloma.
PCOS / Reproductive Endocrine
Rotterdam criteria, hirsutism, irregular cycles, insulin resistance, metabolic workup, and metformin / GLP-1 / oral contraceptive selection.
CGM Review (95251)
Dedicated CGM interpretation visit: time-in-range %, GMI, CV%, time below range, AGP analysis, and the structured 72-hour-minimum report that supports the 95251 bill.
Endocrinology-Specific Features
Built around the language a working endocrinologist actually uses — not generic medical English.
A1c & GLP-1 Titration Tracking
Captures A1c trend, fasting glucose, BMI, and the GLP-1 receptor agonist titration plan (semaglutide 0.25 → 0.5 → 1 → 2 mg weekly; tirzepatide 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg) with the side-effect check at each step.
CGM / AGP Interpretation
Reads time-in-range (TIR 70-180 mg/dL), time-below-range (TBR <70 and <54), GMI, CV%, and AGP pattern analysis from Dexcom Clarity, LibreView, or Tidepool exports — and writes the 95251-eligible report.
Insulin Pump & AID
Documents pump basal segments, insulin-to-carb ratio (ICR), insulin sensitivity factor (ISF), automated insulin delivery (Tandem Control-IQ, Medtronic 780G, Omnipod 5) settings, and pump-site adherence.
Thyroid Panel & Levo Titration
Pulls TSH, free T4, free T3, anti-TPO, anti-Tg, and Tg into the assessment with the levothyroxine dose change and recheck interval that the trend supports.
Adrenal & Pituitary Workups
Captures AM cortisol, ACTH stim test results, 24-hour urine free cortisol, late-night salivary cortisol, dex suppression test, IGF-1, and prolactin in the structured way endocrinology consult letters expect.
CPT 99214 / 95249-95251
Suggests the right E&M level (99213-99215) for clinic and the CGM-specific codes 95249 (personal CGM training), 95250 (professional placement), and 95251 (interpretation, 72-hour minimum) when the documentation supports them.
A real day in endocrine clinic, before and after
A typical outpatient endocrinologist sees 18-25 patients in an 8-hour clinic day. The visits skew long — T2DM titration with five comorbidities and a CGM AGP review, a Graves follow-up with a methimazole change, a hirsutism workup that opens the door to an oral contraceptive and metformin combo. The cognitive load is high. The work that bleeds into the evening is rarely the medicine. It is the consult letters back to primary care, the CGM interpretation reports that anchor 95251 billing, and the prior-auth notes for GLP-1 receptor agonists that keep getting bounced back.
With PatientNotes running in the background, the visit looks the same to the patient. You review the 14-day AGP on the screen together, talk through the post-dinner excursions, decide whether to push semaglutide from 1 mg to 2 mg or to drop the bedtime glargine. The conversation is the documentation. By the time the patient is checked out, the SOAP note, the structured CGM interpretation report (with TIR, TBR, GMI, CV%, and the AGP narrative), and the consult letter to the PCP are drafted and waiting for your signature.
The model is tuned for endocrinology. It knows that "A1c 6.9, TIR 71%, GMI 6.9%" is a coherent picture, that "TSH 6.4 → 1.6 on levo 88" means the dose was titrated correctly, and that "semaglutide 1 mg, planning 2 mg in 4 weeks" needs to land in the plan with the side-effect check. Notes are typically ready 30-90 seconds after the visit — fast enough to review and sign before the next patient knocks.
Sample AI-Generated Endocrinology Note
An actual T2DM + hypothyroid follow-up with CGM interpretation the model would produce. Real GLP-1 plan, real AGP numbers, real CPT mapping for 99214 + 95251.
ENDOCRINOLOGY FOLLOW-UP — T2DM with insulin titration + concomitant hypothyroidism
Date: 04/22/2026 | CPT: 99214 (moderate MDM) + 95251 (CGM interpretation, 72-hour data reviewed)
SUBJECTIVE:
54-year-old female with T2DM (diagnosed 2017) and primary hypothyroidism, returns
12 weeks after starting semaglutide and uptitrating basal insulin. Reports 6 kg
weight loss (now 84 kg from 90 kg). Tolerating semaglutide — initial nausea has
resolved. No hypoglycemia symptoms. Energy "much better" since the levothyroxine
dose change. No constipation, no cold intolerance, no palpitations. Adherent to
medications. Wears Dexcom G7 CGM continuously; 14-day average time-in-range 71%.
PMH: T2DM (since 2017), primary hypothyroidism (since 2014), HTN, dyslipidemia,
stage 1 obesity (down from class II), MASLD on imaging, family history of
T2DM (mother, brother).
MEDICATIONS (reconciled):
- Semaglutide 1 mg subcutaneous weekly (target 2 mg, currently mid-titration)
- Metformin XR 1,000 mg BID
- Insulin glargine (U-100) 26 units at bedtime (down from 32 last visit)
- Levothyroxine 88 mcg daily (up from 75 mcg)
- Lisinopril 20 mg daily; rosuvastatin 20 mg nightly
- ASA 81 mg daily
OBJECTIVE:
Vitals: BP 124/72, HR 72, BMI 31.2 (down from 33.4 — clinical progress), Wt 84 kg.
General: Comfortable, no acute distress.
Neck: Thyroid normal size, no nodules, no tenderness.
Cardiac: Regular rate, S1/S2 normal, no murmur.
Lungs: Clear bilaterally.
Abdomen: Soft, non-tender; BMI-related adiposity, no tenderness.
Extremities: No edema. Distal pulses 2+ symmetric.
Neuro: Monofilament testing — protective sensation intact bilaterally at all
10 sites (annual diabetic foot exam, today).
LABS / DATA (last 4 weeks):
A1c 6.9% (was 8.1% 12 weeks ago — substantial improvement)
Fasting glucose 118 (3-day avg by CGM)
TSH 1.6 (target 0.5-2.5; was 6.4 on prior dose — appropriate)
Free T4 1.2 (within range)
LDL 78 | HDL 52 | TG 142
ALT 26 | AST 22 (improved from prior 48 / 39)
eGFR 84 | UACR 14 mg/g (microalbuminuria absent)
CGM INTERPRETATION (Dexcom G7, 14 days, 100% sensor wear):
Time in range (70-180 mg/dL): 71% (target >=70%)
Time below range (<70): 2% (target <4%)
Time below range (<54): 0% (target <1%)
Time above range (180-250): 24%
Time above range (>250): 3%
Average glucose: 152 mg/dL
GMI: 6.9%
CV (glucose variability): 29% (target <36%)
AGP pattern: post-prandial excursions after dinner most days; otherwise stable.
ASSESSMENT:
1. T2DM, well-controlled — A1c 6.9% (down from 8.1%). CGM TIR 71%, no significant
hypoglycemia. Off the original glargine 32 → 26 because of overnight TBR.
Semaglutide producing expected weight loss (-6 kg) and metabolic improvement.
2. Primary hypothyroidism — euthyroid on levothyroxine 88 mcg, TSH 1.6.
Symptoms resolved.
3. MASLD (NAFLD) — improving alongside weight loss; ALT trended down.
4. Microalbuminuria — absent (UACR 14). Continue ACEi.
5. Dyslipidemia at goal on rosuvastatin 20 mg.
6. Annual diabetes care: foot exam done today (intact). Retinal exam due — order
placed with optometry. Microalbumin done. ACR done. DSME (Diabetes Self-
Management Education) referral renewed.
PLAN:
1. Diabetes:
- Continue semaglutide 1 mg weekly x 4 more weeks, then increase to 2 mg
weekly (target dose). Counseled on injection technique and on holding the
dose if she becomes acutely ill or NPO.
- Continue glargine 26 U HS. May down-titrate to 22 U if TBR exceeds 4% on
next CGM review.
- Continue metformin 1,000 mg BID.
2. Thyroid: continue levothyroxine 88 mcg daily; recheck TSH in 8 weeks.
3. Counseled on Mediterranean-pattern diet, 150 minutes/week moderate exercise.
4. Annual comprehensive eye exam ordered with optometry partner.
5. Follow-up endocrinology in 12 weeks. Repeat A1c, TSH, LDL, ALT/AST, UACR.
Plan to interpret next CGM AGP at that visit (95251 bill expected).
Suggested ICD-10: E11.65 (T2DM with hyperglycemia, currently well-controlled
is captured by E11.9 if A1c <7), E03.9 (hypothyroidism),
E66.01 (obesity), K76.0 (NAFLD/MASLD), Z79.4 (long-term insulin),
Z13.1 (diabetes screening — for family follow-up).
Suggested CPT: 99214 (E&M, moderate MDM), 95251 (CGM interpretation, 72-hour
data reviewed and AGP report generated, signed by physician).Intelligent ICD-10 Suggestions
The codes most endocrine practices bill on a daily basis — surfaced from the documentation, not guessed.
E11.9Type 2 diabetes mellitus without complicationsE11.65Type 2 diabetes mellitus with hyperglycemiaE10.65Type 1 diabetes mellitus with hyperglycemiaE03.9Hypothyroidism, unspecifiedE05.90Thyrotoxicosis, unspecified, without thyroid stormE27.40Adrenal insufficiency, unspecifiedE28.2Polycystic ovarian syndromeE66.01Morbid (severe) obesity due to excess caloriesThe AI suggests relevant codes based on what you actually documented. You review and confirm — there is no auto-billing.
Endocrinologists using PatientNotes today
Three composite stories drawn from real onboarding interviews. Names changed, details preserved.
Dr. Lara Henriksen
Solo endocrinologist, Burlington VT — 4-day clinic
Lara sees 18-22 patients a day, mostly T2DM and thyroid, and runs a half-day a week of CGM-only follow-ups (95251). She used to spend 90 minutes after clinic writing CGM interpretation reports because the structured AGP narrative was tedious. With PatientNotes she records the visit while reviewing the AGP on screen with the patient, and the structured 72-hour-minimum CGM report comes out with TIR, TBR, GMI, and CV% already in the right order. The $50/month fee was inside her practice card; no partner approval needed.
Dr. Vikram Sethi
Mid-size endocrine group, 6 endocrinologists + 2 NPs + 3 CDEs, Tampa FL
Vikram's group had a Suki demo and was quoted around $4,200 per clinician per year on a 24-month contract. They piloted PatientNotes for 60 days first and the partners voted to keep it. They built a shared T1DM-with-pump template that puts pump settings, ICR/ISF, and CGM AGP at the top of the assessment, which made handoff to the CDEs faster. The CDEs can now pre-load adjustments into the patient's pump-clinic note without the endocrinologist re-typing.
Dr. Amelia Costa
Hospital-employed endocrinologist, large academic system, Phoenix AZ
Amelia splits her week between general endocrine clinic and a thyroid-cancer follow-up clinic for post-thyroidectomy patients on TSH suppression. The hospital had Suki rolled out for primary care but had not extended it to endocrinology. She uses PatientNotes for outpatient endocrine days and pastes the structured note into Epic. The thyroid-cancer template puts Tg, anti-Tg, neck US, and TSH-suppression target in the same anchor block every visit, which is what tumor board needed.
Coming from Microsoft Dragon Medical One?
Microsoft Dragon Medical One has been the dictation standard in endocrinology for two decades — long thyroid follow-up letters, complex insulin-titration plans, and pituitary consult letters all moved through Dragon. The newer Microsoft Dragon Copilot adds ambient capture on top. Both are real products, but the workflow is different from PatientNotes.
Dragon Medical One
- •Dictation: you talk to a microphone, the words appear in your EHR or letter generator.
- •Mature voice profile — typically 99% accuracy after a few weeks of training.
- •$99-$200/month per clinician for Dragon Medical One; Dragon Copilot adds ambient at higher tiers ($250+).
- •Strong Epic / Cerner / athenahealth integration via the Dragon plug-in.
- •You still author the structure of the note; Dragon types it for you.
PatientNotes
- •Ambient: you talk to the patient (and review the AGP on screen with them), the note writes itself.
- •No voice training. Works on day one.
- •$50/month flat — no per-encounter fees, no enterprise minimums.
- •No EHR integration required — copy/paste workflow, ready in hours.
- •Generates the SOAP / CGM interpretation / consult-letter structure for you, including 95251 attestation.
How to switch in three steps
Sign up and run a parallel day
For one full clinic day, record encounters in PatientNotes while still using Dragon as your primary. Compare the two notes side by side at the end of the day, particularly your CGM-review notes.
Customize one endocrine template
Pick your highest-volume visit type (most endocrinologists pick T2DM follow-up or CGM interpretation) and customize the structure so titration plan and TIR sit in the order you already use.
Cancel Dragon when you are ready
Most endocrinologists are off Dragon within 5-7 days. Keep it as a backup for the first month if you want — they do not conflict.
PatientNotes vs Suki.ai (and Freed.ai)
Suki and Freed are the two ambient AI scribes most often pitched to endocrine practices. Suki is the enterprise option (deeper Epic integration, higher price), Freed is the indie favorite. We have lost deals to both and we have won deals against both. Here is the honest read for endocrinology.
| Feature | PatientNotes | Suki / Freed |
|---|---|---|
| Monthly price (per clinician) | $50 | Suki $250-$400 / Freed $99-$149 |
| Setup time | Same day | Suki 4-12 weeks (Epic) / Freed same day |
| Contract | Month-to-month | Suki annual, Freed monthly |
| Endocrine templates | T2DM, T1DM pump, thyroid, adrenal, PCOS, CGM 95251 | Available via custom build (Suki) or generic (Freed) |
| CGM interpretation note | Yes — supports 95251 | Suki yes; Freed via free-form |
| GLP-1 / insulin titration tracking | Yes | Yes |
| Epic write-back integration | Copy/paste | Suki direct; Freed copy/paste |
| Best fit | Solo, small/mid group, 1-25 clinicians | Suki: large health system / Freed: solo or duo who like its UI |
If your hospital has already paid for Suki and integrated it into Epic, use what you have. The marginal benefit of switching is small. If you are independent or in a 1-25 clinician group and choosing between Freed and PatientNotes, run a 30-day pilot of both — the templates and the price point are the deciders. Most endocrine practices land on PatientNotes for the price, the customizable CGM-review note, and not having to negotiate template builds.
Frequently Asked Questions
Real questions from endocrinology onboarding calls.
Does PatientNotes work for endocrinology?
Yes. PatientNotes is used by general endocrinologists, diabetologists, thyroid specialists, and reproductive endocrinologists. The model is tuned for endocrine language, so it correctly captures A1c trends, GLP-1 receptor agonist titration (semaglutide, tirzepatide, liraglutide), insulin pump and CGM data interpretation (time-in-range %, GMI, CV%, time below range), thyroid panels (TSH, free T4, free T3, anti-TPO, Tg), adrenal axis testing (AM cortisol, ACTH stim, 24-hour urine free cortisol), and PCOS workup (Rotterdam criteria). It outputs SOAP notes for clinic, the CGM interpretation note that supports CPT 95251, and consult letters back to the referring PCP or OB.
How much does an AI scribe cost for endocrinology?
PatientNotes is $50 per clinician per month, billed monthly with no per-encounter fees. Suki.ai typically runs $250-$400 per clinician per month for endocrinology and Freed.ai runs around $99-$149 per month — both with annual contracts in most cases. For an endocrinologist seeing 18-22 patients per day, the difference vs Suki is roughly $2,400-$4,200 per year and vs Freed is $600-$1,200 per year. The pricing matters because endocrine practices tend to run thin on margin and high on labor — every dollar saved on documentation tools tends to fund another half-hour of CDE / RN time.
Is Suki or Freed better than PatientNotes for endocrinology?
Suki has deeper Epic and Cerner integration and a more polished mobile app, which helps if your hospital mandates Epic write-back. Freed is closest to PatientNotes on workflow — both are ambient scribes used by independent and small-group clinicians. PatientNotes is cheaper than both, deploys same-day, and produces equivalent-quality endocrine notes in the side-by-side reviews we run with practicing endocrinologists. If your group is already on Suki through an enterprise deal, use what you have. If you are independent, in a small group, or just frustrated with Freed pricing or template flexibility, PatientNotes is almost always the better fit.
Can endocrinology-specific notes be auto-generated?
Yes. PatientNotes ships with endocrinology templates for T2DM follow-up, T1DM with insulin pump or CGM, thyroid follow-up (hypothyroid, hyperthyroid, post-thyroidectomy), adrenal evaluation, PCOS evaluation, pituitary follow-up, osteoporosis (FRAX, DXA review), and the dedicated CGM / FGM interpretation note that anchors the 95251 bill. You can customize templates so the assessment always opens with A1c and time-in-range, then medication titration, then comorbidity screening (microalbumin, foot exam, retinal exam), which is the order most endocrine practices already use.
Does it integrate with Epic and athenahealth for endocrinology?
PatientNotes works alongside Epic, Cerner, athenahealth, eClinicalWorks, NextGen, and any specialty endocrine module. The note is generated in PatientNotes and pasted into your EHR using a one-click copy. We do not require a write-back integration, which is what lets us deploy in a day instead of the 6-8 weeks an Epic App Orchard project takes. It also pairs naturally with CGM data exports from Dexcom Clarity, LibreView, and Tidepool — paste the time-in-range / GMI summary alongside the visit and the model will incorporate it into the assessment.
Will it help me bill endocrinology CPT correctly?
PatientNotes suggests E&M codes (99213-99215) based on documented MDM (medical decision making) and surfaces the endocrine-specific codes correctly: 95249 (personal CGM startup, training), 95250 (professional CGM placement, sensor included), 95251 (CGM interpretation and report, 72-hour minimum), G0108/G0109 (DSMT — diabetes self-management training), G0270/G0271 (MNT — medical nutrition therapy follow-up), and the 99406/99407 tobacco-cessation add-ons that frequently apply. It does not auto-bill — you review and confirm each code, which is the audit-defensible pattern.
How do I switch from Dragon Medical One to PatientNotes?
Three steps. First, sign up at patientnotes.ai and complete the 5-minute clinician onboarding. Second, run PatientNotes in parallel with Dragon for one full clinic day — record the encounter in PatientNotes, then dictate with Dragon as you normally would. Compare the two notes side by side. Third, when ready, retire Dragon. Most endocrinologists make the switch in under a week. Dragon is dictation; PatientNotes is ambient — the conversation about the A1c, the GLP-1 titration, and the time-in-range becomes the note automatically, including the CGM interpretation block that supports 95251.
Is it HIPAA compliant for endocrinology?
Yes. PatientNotes is HIPAA compliant, signs a Business Associate Agreement (BAA) with every practice on request, and encrypts audio and notes at rest and in transit. Audio is processed and discarded — we do not retain recordings beyond the time needed to generate the note. Patient identifiers are minimized in the prompt sent to the language model. We do not train models on your data. Most independent endocrine practices that have completed a basic HIPAA risk assessment can onboard PatientNotes without a separate IT review.
Finish CGM reports and titration plans before the next patient knocks.
Endocrinologists on PatientNotes save 60-90 minutes of charting per clinic day — the difference between dinner with the family and signing notes after the kids are asleep.
No credit card required. $50/month after trial. Cancel anytime.